- Tytuł:
- Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis
- Autorzy:
- Źródło:
- In Journal of the Neurological Sciences 15 October 2019 405 Supplement:308-309
Czasopismo naukowe